CORPORATE STRATEGY

TECHNOLOGY ANALYSIS

I have participated in technology analysis and diligence to support of over $400M in acquisitions and internal development and deployment of novel biotechnology platforms and first-in-class products reviewed by FDA, USDA, EPA and USFWS regulators.
read more...